Related Experiment Video
Updated: May 31, 2026

Laser Capture Microdissection of Mouse Embryonic Cartilage and Bone for Gene Expression Analysis
Published on: December 18, 2019
Myostatin (GDF-8) inhibits chondrogenesis and chondrocyte proliferation in vitro by suppressing Sox-9 expression
Moataz Elkasrawy1, Sadanand Fulzele, Matthew Bowser
1Department of Cellular Biology & Anatomy, Medical College of Georgia , Georgia Health Sciences University, Augusta, USA.
Abstract:
Here, we investigate a possible direct role for myostatin in chondrogenesis. First, we examined the effects of myostatin on the proliferation of bone marrow stromal cells (BMSCs) and epiphyseal growth plate (EGP) chondrocytes (EGPCs) isolated from myostatin-deficient mice. Results show that myostatin deficiency is associated with a significant (P < 0.001) increase in proliferation of both BMSCs (+25%) and EGPCs (+35%) compared with wild-type cells. Next, we examined the effects of myostatin treatment on chondrogenic differentiation of BMSCs. These experiments show that myostatin treatment starting at either 0 or 48 h induces a significant decrease in collagen type II protein synthesis by 31% (P < 0.001) and 25% (P < 0.05), respectively. Real-time PCR reveals significant (P < 0.01) down regulation of Sox9 mRNA expression with 10 and 100 ng/ml treatments. Together, these findings suggest that myostatin has direct effects on chondrogenesis, and may, therefore, represent a potential therapeutic target for improving bone repair.
Insights
Myostatin deficiency increases bone marrow stromal cell and growth plate chondrocyte proliferation. Myostatin treatment inhibits chondrogenic differentiation, suggesting it
Area of Science:
- Cell Biology
- Developmental Biology
- Orthopedics
Background:
- Myostatin is a key regulator of muscle growth.
- Its role in chondrogenesis, the process of cartilage formation, is not fully understood.
- Understanding myostatin's function in cartilage development is crucial for bone repair.
Purpose of the Study:
- To investigate the direct role of myostatin in chondrogenesis.
- To examine the effects of myostatin deficiency and treatment on chondrocyte proliferation and differentiation.
- To assess myostatin as a potential therapeutic target for bone repair.
Main Methods:
- Studied proliferation of bone marrow stromal cells (BMSCs) and epiphyseal growth plate chondrocytes (EGPCs) from myostatin-deficient mice.
- Assessed the impact of myostatin treatment on BMSC chondrogenic differentiation.
- Utilized real-time PCR to analyze Sox9 mRNA expression and measured collagen type II protein synthesis.
Main Results:
- Myostatin deficiency significantly increased BMSC (+25%) and EGPC (+35%) proliferation compared to wild-type.
- Myostatin treatment significantly decreased collagen type II synthesis by 31% (0h) and 25% (48h).
- Myostatin treatment (10-100 ng/ml) significantly downregulated Sox9 mRNA expression.
Conclusions:
- Myostatin directly impacts chondrogenesis by inhibiting chondrocyte proliferation and differentiation.
- Myostatin plays a suppressive role in cartilage formation.
- Myostatin represents a potential therapeutic target for enhancing bone repair and regeneration.
Related Concept Videos
Master Transcription Regulators
Formation of Muscle Fibers from Myoblasts
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription factors...
Bone Formation by Endochondral Ossification
Satellite Stem Cells and Muscular Dystrophy
TGF - β Signaling Pathway
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...

